Monografie
Pathways to products: exploring the biosynthetic depth of Myxococcus xanthus by comprehensive secondary metabolite profiling
- Sprache
-
Englisch
- Anmerkungen
-
Saarbrücken, Universität des Saarlandes, Diss., 2013
- Identifier
-
1074404602
Thema
Myxococcus xanthus ; Metabolom ; Sekundärmetabolit ; Bioaktive Verbindungen ; Biosynthese ; Massenspektrometrie ; Naturstoff; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Objekttyp
- Monografie
Beteiligte
- Cortina, Niña Socorro
- Müller, Rolf
Ähnliche Objekte (12)
Natural product biosynthesis in myxobacteria : studies on enzymatic versatility and secondary metabolite diversity
Deciphering novel mechanisms of bacterial secondary metabolite biosynthetic pathways
Novel secondary metabolites from myxobacteria and their biosynthetic machinery
Isolation, characterisation and biosynthetic precursors of natural products from myxobacteria
Investigation of bacterial secondary metabolite pathways from Sorangium cellulosum
Exploring the biosynthetic potential of Cystobacter fuscus : characterization of new structures and studies on their biosynthesis
Studies on the biosynthesis and heterologous expression of tubulysin
Isolation and structure elucidation of secondary metabolites from the gliding bacteria Ohtaekwangia kribbensis and Hyalangium minutum
Synthese und biologische Evaluation von Chondramid-Derivaten
Screening for myxobacterial natural products : new structures, biosynthesis, and contributions to a comprehensive screening workflow
Mode-of-Action studies on cytostatic compounds from myxobacteria : antimitotic pretubulysins and actin-targeting chondramides
Isolation and characterization of novel natural compounds from Myxobacteria
Natural product biosynthesis in myxobacteria : studies on enzymatic versatility and secondary metabolite diversity
Deciphering novel mechanisms of bacterial secondary metabolite biosynthetic pathways
Novel secondary metabolites from myxobacteria and their biosynthetic machinery
Isolation, characterisation and biosynthetic precursors of natural products from myxobacteria
Investigation of bacterial secondary metabolite pathways from Sorangium cellulosum
Exploring the biosynthetic potential of Cystobacter fuscus : characterization of new structures and studies on their biosynthesis
Studies on the biosynthesis and heterologous expression of tubulysin
Isolation and structure elucidation of secondary metabolites from the gliding bacteria Ohtaekwangia kribbensis and Hyalangium minutum
Synthese und biologische Evaluation von Chondramid-Derivaten
Screening for myxobacterial natural products : new structures, biosynthesis, and contributions to a comprehensive screening workflow
Mode-of-Action studies on cytostatic compounds from myxobacteria : antimitotic pretubulysins and actin-targeting chondramides
Isolation and characterization of novel natural compounds from Myxobacteria
Natural product biosynthesis in myxobacteria : studies on enzymatic versatility and secondary metabolite diversity
Deciphering novel mechanisms of bacterial secondary metabolite biosynthetic pathways
Novel secondary metabolites from myxobacteria and their biosynthetic machinery
Isolation, characterisation and biosynthetic precursors of natural products from myxobacteria
Investigation of bacterial secondary metabolite pathways from Sorangium cellulosum
Exploring the biosynthetic potential of Cystobacter fuscus : characterization of new structures and studies on their biosynthesis
Studies on the biosynthesis and heterologous expression of tubulysin
Isolation and structure elucidation of secondary metabolites from the gliding bacteria Ohtaekwangia kribbensis and Hyalangium minutum
Synthese und biologische Evaluation von Chondramid-Derivaten
Screening for myxobacterial natural products : new structures, biosynthesis, and contributions to a comprehensive screening workflow
Mode-of-Action studies on cytostatic compounds from myxobacteria : antimitotic pretubulysins and actin-targeting chondramides